HCP Live covers significant developments in the field of gastroenterology during December 2023. Key highlights include: American Gastroenterological Association (AGA) Guidelines: The AGA released two important guidelines in December. The first set of guidelines focuses on the use of biomarkers in managing Crohn’s Disease (CD), offering 11 conditional recommendations based on evidence and expert consensus. These guidelines emphasize the role of serum and fecal biomarkers as surrogates for endoscopic disease activity in CD. The second guideline pertains to the management of pouchitis and inflammatory pouch disorders, marking the first comprehensive evidence-based guideline in this area. Qazi Corner’s Fourth Installment: This…
Author: Abhay Panchal
Watch this amazing recap of The Scope Forward Show 2023 (Season 3). Risks in GI. Non-invasive testing. Breaking rules. Having a backup plan. Stool detection app. Reimbursement for AI. Self driving endoscopy. Lead, don’t get left behind. Endoscopy robots as part of the team. Value of data in GI. Precision medicine. Unconventional ideas. Thank YOU guests for the amazing work you do, for being so candid, and for making The Scope Forward Show one of the most influential podcasts in gastroenterology.
Cigna, which is the fourth largest insurer in the U.S. by membership size, is considering the sale of its Medicare Advantage business. Here are seven additional stories on the company that Becker’s has reported on since Nov. 2:
Join Tim O’Connell, a physician executive. In this episode, we explore the fascinating world of medical-grade AI and its transformative impact on health care. Tim provides valuable insights into the evolution of AI in medicine, recent advancements, and practical applications that are reshaping the future of patient care. Tim O’Connell is a physician executive.He discusses the KevinMD article, “The clinical AI revolution: 3 things to know.”
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a five-year, $3 million grant from the National Cancer Institute. The grant is aimed at developing artificial intelligence (AI) to detect and predict aggressive prostate cancer. This initiative is crucial in helping to avoid unnecessary treatments and their associated negative side effects. Key aspects of the project include: Addressing Overdiagnosis and Overtreatment: Prostate cancer is a common and serious health issue for men. Current screening and risk assessment methods often lead to overdiagnosis and overtreatment. Approximately 90% of people diagnosed with prostate cancer receive treatment, though up to…
The Becker’s ASC Review article explores the impact of artificial intelligence (AI) on Ambulatory Surgery Centers (ASCs) and healthcare in general. Key points from the article include: AI’s Growing Role in Healthcare: AI has seen a significant surge in healthcare over the past year, and surgery center leaders are closely monitoring its impact. The question is whether AI will make surgery centers more efficient or add complexity to their operations. Cautious Adoption of AI in Healthcare: Healthcare is traditionally slow to adopt new technologies due to high stakes and stringent regulations. Slim margins in the industry mean that every technology…
The article from The Medical Futurist outlines the significant milestones achieved in the field of artificial intelligence (AI) in medicine during 2023. Key highlights include: Rise of ChatGPT: In November 2022, OpenAI launched ChatGPT, a large language model that quickly gained popularity, reaching over 100 million users in just two months. This marked a significant shift in the public’s access to and interaction with AI, particularly in the medical field. Development of GPT-4: Following the success of ChatGPT, OpenAI released GPT-4, an even more advanced model. This development opened up new possibilities for future use cases in healthcare. Healthcare-Specific AI…
In patients with inflammatory bowel disease, neither biologics nor small molecule targeted therapies increase the risk for major adverse cardiac events, according to the largest study to address this question. Biologics were associated with a reduced risk for both major adverse cardiac events (MACE) and venous thromboembolism (VTE) relative to no biologics. Small molecule therapies, such as Janus kinase (JAK) inhibitors, were associated with a neutral effect. “Hopefully these data comfort us,” said investigator Miguel Regueiro, MD, the chair of the Digestive Disease & Surgery Institute at Cleveland Clinic, in Ohio. Dr. Regueiro also expressed hope these data might change…
The article from Cureus focuses on the advancements in early cancer detection, exploring the roles of biomarkers, circulating DNA (ctDNA), and innovative technological approaches. Key points from the article include: Importance of Early Cancer Detection: Early detection of cancer is crucial for improving patient prognoses and increasing the chances of a full recovery. Screening plays a significant role in detecting cancer at early stages, potentially before symptoms arise and ideally before metastasis. Challenges and Opportunities in Early Detection: The article discusses the challenges in early cancer detection, such as the need for identifying consequential illnesses that might cause significant morbidity…
The Yahoo Finance article discusses predictions for how artificial intelligence (AI) will impact various aspects of healthcare in 2024. The article includes insights from experts in the field, highlighting several key areas where AI is expected to make significant contributions: AI in Healthcare Administration: AI is expected to play a major role in streamlining administrative tasks in healthcare. Companies like Microsoft, Amazon, and Google are developing next-generation tech to relieve doctors and medical staff from burdensome administrative duties. Health insurers are also exploring AI to automate the claims process. Impact on Productivity and Costs: AI could boost productivity, reduce costs,…